Essex Investment Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59,760
Closed -$5.02M 397
2023
Q2
$5.02M Sell
59,760
-10,820
-15% -$828K 0.7% 35
2023
Q1
$5.35M Buy
70,580
+10,088
+17% +$698K 0.78% 29
2022
Q4
$3.73M Sell
60,492
-12,348
-17% -$656K 0.58% 47
2022
Q3
$3.04M Sell
72,840
-16,365
-18% -$712K 0.49% 63
2022
Q2
$2.81M Buy
89,205
+2,982
+3% +$79.5K 0.45% 66
2022
Q1
$2.32M Buy
86,223
+3,968
+5% +$71.1K 0.29% 104
2021
Q4
$1.58M Buy
82,255
+6,396
+8% +$160K 0.18% 170
2021
Q3
$2.51M Sell
75,859
-488
-0.6% -$14.9K 0.31% 103
2021
Q2
$2.53M Sell
76,347
-6,716
-8% -$186K 0.29% 109
2021
Q1
$3.45M Buy
+83,063
New +$2.56M 0.42% 68
2020
Q3
Sell
-84,455
Closed -$1.51M 502
2020
Q2
$1.51M Buy
+84,455
New +$1.32M 0.25% 129
2019
Q4
Sell
-24,631
Closed -$585K 509
2019
Q3
$585K Hold
24,631
0.08% 278
2019
Q2
$714K Buy
+24,631
New +$672K 0.1% 261

Other funds holding TMDX

Essex Investment Management's TMDX Position: Q3 2023 in Review

Essex Investment Management sold out of Transmedics (TMDX) in Q3 2023, closing a stake of 59,760 shares — an estimated $5.02M sold.

Essex Investment Management first reported a position in TMDX in Q2 2019 and held it in 13 quarters. The position peaked at $5.35M in Q1 2023. 221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

  • Essex Investment Management reported no remaining Transmedics position as of Q3 2023 after selling out during the quarter.
  • Essex Investment Management sold 59,760 Transmedics shares in Q3 2023, an estimated $5.02M.
  • Essex Investment Management first reported a position in Transmedics in Q2 2019 and held it in 13 quarters.
  • Essex Investment Management's Transmedics position peaked at $5.35M in Q1 2023.
  • 221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on Essex Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.